Aortech Share Discussion Threads

[mikeh30] 11/12/2017 12:36

Huge weekly rerate to come here. 80p-£1 today

[the stigologist] 11/12/2017 12:35

Breast implants?

"Your Board still believes there to be substantial benefits in utilising Elast-Eon™ technology in cosmetic and reconstructive surgery and as a result recently terminated this licence in order to pursue other opportunities in the field."

[redfox05] 11/12/2017 12:35

haha LOL amrishbhim. Im no friend of whoever dave is. Deramper lol? aww thats cute. but wrong :P might want to bark up another tree, jus sayin.
I just bought in here. Merely suggesting a post on key rise reasons to encourage others.

anyways, back up again, looks like the shaking might be over

[the stigologist] 11/12/2017 12:34

The potential to use this FDA approved technology in other implantable medical devices whether cosmetic or medical is immense.

i.e. just the breast implant market alone is huge !

[the stigologist] 11/12/2017 12:33

AOR

My research summary from prior to this morning

Aortech (AOR)

sp 22.5p
shares o/s 5.6m
mkt cap £1.2m

AorTech has developed biostable, implantable polymers, including Elast-Eon™ and ECSil™ the world's leading long-term implantable co-polymers, now manufactured on their behalf by Biomerics LLC in Utah, USA. With several million implants and seven years of successful clinical use, AorTech polymers are being developed and used in cardiology and urological applications, including pacing leads, cardiac cannulae, stents and neuro stimulation devices. Devices manufactured from AorTech polymers have numerous US FDA PMA approvals, 510k's, CE Marks, Australian TGA and Japanese Ministry of Health approvals.

Elast-Eon™ and ECSil™'s biostability is comparable to silicone while exhibiting excellent mechanical, blood contacting and flex-fatigue properties. These polymers can be processed using conventional thermoplastic extrusion and moulding techniques. A range of materials in a variety of application-specific formulations for use in medical devices and components are available.

Financials
Revenue $614k
Profit $55k
Cash $114k

Upside ?
1. Change in licensing strategy
"Our manufacturing licensee, Biomerics concluded a licence for Elast-Eon™ earlier this year together with a long term supply agreement. There are currently a number of companies evaluating Elast-Eon™ which if succesful may lead to other licences. Biomerics adopts a different approach to licensing to that which AorTech has historically pursued. AorTech signed a number of licences with very small/development companies long before products were ready for market launch. As a result, other than annual maintenance fees, the revenues from those licences depended upon future product launches. By contrast, Biomerics is focussed on volume supply and near term success."

2.Additional licensing opportunities
Some historic licences signed by the Company have not generated value for AorTech and have only resulted in the Elast-Eon™ material not being exploited in the field of the licence. An example of this was the licence for breast implants signed in 2011. Since that time, AorTech's technology has not been incorporated into any new device nor generated any revenue for AorTech despite maintaining an IP portfolio in this arena. Your Board still believes there to be substantial benefits in utilising Elast-Eon™ technology in cosmetic and reconstructive surgery and as a result recently terminated this licence in order to pursue other opportunities in the field.

Outlook/Conclusion (from August 15th Final Results RNS)

"A new revenue-generating licence has been signed and enquiries have increased markedly. We have taken back control of our breast implant IP and are actively pursuing opportunities to exploit this alongside our other intellectual property, including heart valves and polymers."



-------------------------------

Interesting stakebuilding.

Former CEO who resigned in Oct 2016 went above 10% holding in Sept 2017

Litigation

They were suing another former CEO but looks like settlement on that soon. Just drawing a line under it should be positive.


---------------------------------

hxxp://biomerics.com/elast-eon-bringing-quality-value-medical-device-project/

[amrishbhim] 11/12/2017 12:31

And than you have redfox from little red riding hood another deramper a friend of Dave

[mikeh30] 11/12/2017 12:31

Well the fact they say the share price was based on Aortech failing (which it is not) is a good place to start

[amrishbhim] 11/12/2017 12:30

And than you have Dave , it was going to happen sooner, a deramper,

[redfox05] 11/12/2017 12:29

what are the key reasons for the rise?

[dave4545] 11/12/2017 12:28

So they made $32,000 profit in 6 months, not sure if the AIM listing costs come under Administration costs but they certainly need to increase the monies coming in to justify the hike today in their market cap

[the stigologist] 11/12/2017 12:27

This is how PYC multi-bagged over 3 days

1p to 30p

I was there from the start.

This is looking exactly the same...

[dave4545] 11/12/2017 12:25

Nearly 4 mil cap.

Over the six month period to 30 September 2017, revenues increased to $271,000 from the $240,000 achieved in the corresponding period last year. Administration costs were again tightly controlled at $239,000 - a reduction of $110,000 compared to the same period last year - and at similar levels to the second half of the last financial year.

Yes the litigation news today is good but the current valuation is crazy. People just pile blind into the biggest % riser, it will end in tears for many

[the stigologist] 11/12/2017 12:25

no profit taking from me

I WILL BUY INTO THE CLOSE TODAY

Just like I did with PYC the first day it ended around 3-4p

Next day it was up to 10p

Next day it went to 30p intraday

[mikeh30] 11/12/2017 12:23

This is going to look a bit like PYC

[spawny100] 11/12/2017 12:23

Any guesses where this is going to end up today. Surely not another PYC so soon after that once in a lifetime one?

[redfox05] 11/12/2017 12:23

Looks like there will be quite a bit of profit sells now but then lots of quick buys for newcomers who want to just see any spot to get in

[redfox05] 11/12/2017 12:21

wtf, I glance back at level 2 and this is about to DOUBLE? I glanced away for 3 mins!! 130% to 192%!

[abeygale] 11/12/2017 12:18

Stig was known as a serial deramper before and now he is doing the complete opposite. Investors will end up stuck here like they was with ZIOC at 26p.

[deanmatlazin] 11/12/2017 12:17

market cap still £3m. I am having a laugh. Still cheap as chips. Litigation over. it was £3/ share .

[mikeh30] 11/12/2017 12:17

The long-running litigation dispute created a number of uncertainties for AorTech and its shareholders and at the time of announcing results for the year to 31 March 2017 the share price was implying that AorTech was likely to fail.Not going to fail now. £2.5m cap. Used to trade between 500-1000p when it wasn't priced to fail

[dave4545] 11/12/2017 12:16

Bonkers rise. Interims out too.

But it's so illiquid it's now a ponzi how high will people be prepared to chase it to before the hype dies down.

[dave4545] 11/12/2017 12:14

Expecting falia/letmepass/shirley/miahkaysor to turn up any moment now

[dave4545] 11/12/2017 12:13

Funny how you always turn up on the biggest % winner colin well after the event and say you bought earlier !

sniff sniff what's that smell ?

[colin12345678] 11/12/2017 12:12

Stig took some more this morning thanks for the heads uo the other day